Viemed Healthcare (VMD)
(Real Time Quote from BATS)
$8.09 USD
+0.08 (1.00%)
Updated Apr 26, 2024 01:13 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Viemed Healthcare, Inc. [VMD]
Reports for Purchase
Showing records 1 - 18 ( 18 total )
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for VMD 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Q2 Results Rebound but Regulatory Issues Still Create Uncertainty
Provider: Beacon Securities Ltd.
Analyst: COOPER D
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
A Little Slow Out of the Gate but Historic Patient Momentum Returning
Provider: Beacon Securities Ltd.
Analyst: COOPER D
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Record Year in FY20 and Historical Growth Rate Should Return in FY21 to Drive Another One
Provider: Beacon Securities Ltd.
Analyst: COOPER D
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Initiating coverage with an ACCUMULATE rating and a US$11.00 per share target price.
Provider: Bloom Burton & Company
Analyst: Research Department
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Company: Viemed Healthcare, Inc.
Industry: Medical - Products
Results Like a Breath of Fresh Air - Raising Target
Provider: Beacon Securities Ltd.
Analyst: COOPER D
|